Back to GetFilings.com



Table of Contents

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 


 

 

FORM 10-Q

(Mark One)

 

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    

 

For  the quarterly period ended June 30, 2003.

 

OR

 

¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    

 

For the transition period from                                  to                                 

 

Commission file number: 0-27718

 

 

NEOSE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   13-3549286
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

102 Witmer Road

Horsham, Pennsylvania

 

19044

(Zip Code)

(Address of principal executive offices)    

 

(215) 315-9000

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes x         No ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

Yes x         No ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 17,250,707 shares of common stock, $.01 par value, were outstanding as of August 4, 2003.

 

 



Table of Contents

NEOSE TECHNOLOGIES, INC.

(a development-stage company)

 

INDEX

 

          Page

PART I.

   FINANCIAL INFORMATION:     

Item 1.

   Financial Statements (unaudited)     
     Balance Sheets at December 31, 2002 and June 30, 2003    3
     Statements of Operations for the three and six months ended June 30, 2002 and 2003, and for the period from inception through June 30, 2003    4
     Statements of Cash Flows for the six months ended June 30, 2002 and 2003, and for the period from inception through June 30, 2003    5
     Notes to Financial Statements    6

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    9

Item 3.

   Quantitative and Qualitative Disclosure About Market Risk    17

Item 4.

   Controls and Procedures    18

PART II.

   OTHER INFORMATION:     

Item 4.

   Submission of Matters to a Vote of Security Holders    19

Item 6.

   Exhibits and Reports on Form 8-K    20

SIGNATURES

   21

 

2


Table of Contents

PART I.     FINANCIAL INFORMATION

 

Item 1.     Financial Statements

 

NEOSE TECHNOLOGIES, INC.

(a development-stage company)

 

BALANCE SHEETS

(unaudited)

(in thousands, except per share amounts)

 

Assets    December 31,
2002


    June 30,
2003


 

Current assets:

                

Cash and cash equivalents

   $ 31,088     $ 31,584  

Marketable securities

     9,952       10,486  

Restricted funds

     977       379  

Prepaid expenses and other current assets

     558       1,419  
    


 


Total current assets

     42,575       43,868  

Property and equipment, net

     36,508       35,548  

Acquired intellectual property, net

     2,507       2,209  

Other assets

     1,502       2,246  
    


 


Total assets

   $ 83,092     $ 83,871  
    


 


Liabilities and Stockholders’ Equity             

Current liabilities:

                

Current portion of long-term debt

   $ 1,851     $ 2,803  

Accounts payable

     1,127       1,177  

Accrued compensation

     1,339       1,602  

Accrued expenses

     1,880       1,639  

Deferred revenue

     320       70  
    


 


Total current liabilities

     6,517       7,291  

Long-term debt

     5,560       6,278  

Other liabilities

     330       641  
    


 


Total liabilities

     12,407       14,210  
    


 


Stockholders’ equity:

                

Preferred stock, $.01 par value, 5,000 shares authorized, none issued

     —         —    

Common stock, $.01 par value, 30,000 shares authorized; 14,330 and 17,248 shares issued; 14,324 and 17,242 shares outstanding

     143       172  

Additional paid-in capital

     178,945       195,506  

Treasury stock, 6 shares at cost

     (175 )     (175 )

Deferred compensation

     (170 )     (137 )

Deficit accumulated during the development-stage

     (108,058 )     (125,705 )
    


 


Total stockholders’ equity

     70,685       69,661  
    


 


Total liabilities and stockholders’ equity

   $ 83,092     $ 83,871  
    


 


 

The accompanying notes are an integral part of these financial statements.

 

3


Table of Contents

NEOSE TECHNOLOGIES, INC.

(a development-stage company)

 

STATEMENTS OF OPERATIONS

(unaudited)

(in thousands, except per share amounts)

 

    

Three months

ended June 30,


   

Six months

ended June 30,


   

Period from
inception
(January 17,
1989) to

June 30,
2003


 
     2002

    2003

    2002

    2003

   

Revenue from collaborative agreements

   $ 1,561     $ 651     $ 2,332     $ 721     $ 18,167  
    


 


 


 


 


Operating expenses:

                                        

Research and development

     5,139       6,664       10,974       12,284       111,961  

Marketing, general and administrative

     3,289       3,197       6,209       6,201       55,274  
    


 


 


 


 


Total operating expenses

     8,428       9,861       17,183       18,485       167,235  
    


 


 


 


 


Operating loss

     (6,867 )     (9,210 )     (14,851 )     (17,764 )     (149,0680  

Other income

     —         —         —         —         7,773  

Interest income

     419       147       848       317       19,095  

Interest expense

     (42 )     (163 )     (82 )     (200 )     (3,505 )
    


 


 


 


 


Net loss

   $ (6,490 )   $ (9,226 )   $ (14,085 )   $ (17,647 )   $ (125,705 )
    


 


 


 


 


Basic and diluted net loss per share

   $ (0.45 )   $ (0.54 )   $ (0.99 )   $ (1.07 )        
    


 


 


 


       

Weighted-average shares outstanding used in computing basic and diluted net loss per share

     14,281       17,229       14,201       16,519          
    


 


 


 


       

 

The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

NEOSE TECHNOLOGIES, INC.

(a development-stage company)

 

STATEMENTS OF CASH FLOWS

(unaudited)

(in thousands)

 

    

Six months ended

June 30,


    Period from
inception
(January 17, 1989)
to June 30, 2003


 
     2002

    2003

   

Cash flows from operating activities:

                      

Net loss

   $ (14,085 )   $ (17,647 )   $(125,705 )

Adjustments to reconcile net loss to cash used in operating activities:

                      

Depreciation and amortization

     1,382       2,234     15,343  

Non-cash compensation

     1,162       110     4,883  

Common stock issued for non-cash and other charges

     —         —       35  

Changes in operating assets and liabilities:

                      

Prepaid expenses and other current and non-current assets

     (768 )     (834 )   (1,644 )

Accounts payable

     1,363       50     1,177  

Accrued compensation

     588       (199 )   1,184  

Accrued expenses

     (1,264 )     (139 )   1,639  

Deferred revenue

     (208 )     (250 )   70  

Other liabilities

     —         (108 )   222  
    


 


 

Net cash used in operating activities

     (11,830 )     (16,783 )   (102,796 )
    


 


 

Cash flows from investing activities:

                      

Purchases of property and equipment

     (11,533 )     (722 )   (47,830 )

Proceeds from sale-leaseback of equipment

     —         —       1,382  

Purchases of marketable securities

     (47,487 )     (23,735 )   (408,473 )

Proceeds from sales of marketable securities

     —         8,328     19,795  

Proceeds from maturities of and other changes in marketable securities

     —         15,000     378,860  

Purchase of acquired technology

     —         —       (4,550 )

Investment in equity securities

     —         —       (1,250 )
    


 


 

Net cash used in investing activities

     (59,020 )     (1,129 )   (62,066 )
    


 


 

Cash flows from financing activities:

                      

Proceeds from issuance of debt

     —         2,954     17,170  

Repayment of debt

     —         (1,657 )   (9,809 )

Restricted cash related to debt

     (556 )     598     (308 )

Proceeds from issuance of preferred stock, net

     —         —       29,497  

Proceeds from issuance of common stock, net

     —         16,435